Phyllis Gardner
Director/Board Member chez FIREBRICK PHARMA LIMITED
Fortune : 901 085 $ au 31/03/2024
Profil
Phyllis I.
Gardner is the founder of Genomics Collaborative, Inc. She currently holds the following positions: Independent Director at MiMedx Group, Inc. since 2021, Director-Fellows Board at Harvard Medical School since 2013, Non-Executive Director at Firebrick Pharma Ltd.
since 2020, Director at Aronex Pty Ltd., Professor at Stanford University since 1984, and Advisors at Avestria Ventures Management, LLC.
She has formerly worked as a Director at Pharmacyclics LLC, BioMarin Pharmaceutical, Inc., Aerogen, Inc., and Ventaira Pharmaceuticals, Inc. She was also an Independent Director at CohBar, Inc. from 2019 to 2022, a Director at Draupnir LLC, an Independent Non-Executive Director at Corium International, Inc. from 2007 to 2018, an Independent Director at Parnell Pharmaceuticals Holdings Ltd.
from 2014 to 2015, and an Independent Director at Revance Therapeutics, Inc. from 2006 to 2021.
Additionally, she served as Vice President-Research & Principal Scientist at ALZA Corp.
from 1994 to 1998 and as an Adjunct Partner at Essex Woodlands Management, Inc. from 1999 to 2009.
Dr. Gardner's education includes an undergraduate degree from the University of Illinois and a doctorate from Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MIMEDX GROUP, INC.
0,08% | 13/06/2023 | 117 024 ( 0,08% ) | 901 085 $ | 31/03/2024 |
Postes actifs de Phyllis Gardner
| Sociétés | Poste | Début |
|---|---|---|
| MIMEDX GROUP, INC. | Director/Board Member | 08/03/2021 |
| FIREBRICK PHARMA LIMITED | Director/Board Member | 13/11/2020 |
| Aronex Pty Ltd. | Director/Board Member | - |
| Harvard Medical School | Corporate Officer/Principal | 01/04/2013 |
| Stanford University | Corporate Officer/Principal | 01/01/1984 |
Avestria Ventures Management, LLC
 Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | Consultant / Advisor | - |
Anciens postes connus de Phyllis Gardner
| Sociétés | Poste | Fin |
|---|---|---|
| COHBAR, INC. | Director/Board Member | 15/06/2022 |
| REVANCE THERAPEUTICS, INC. | Director/Board Member | 05/05/2021 |
| CORIUM INTERNATIONAL INC | Director/Board Member | 27/11/2018 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Phyllis Gardner
| University of Illinois | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| REVANCE THERAPEUTICS, INC. | Health Technology |
| COHBAR, INC. | Health Technology |
| PARNELL PHARMACEUTICALS HOLDINGS LTD | Health Technology |
| FIREBRICK PHARMA LIMITED | Health Technology |
| MIMEDX GROUP, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Aerogen, Inc.
 Aerogen, Inc. Medical SpecialtiesHealth Technology Aerogen, Inc. develops and manufactures aerosol products for treatment of respiratory disorders in the critical care setting. Its products include Aerogen Solo, Aerogen Ultra, Aerogen Pro, Pro-C controller, and USB controller. The company is headquartered in Deerfield, IL. | Health Technology |
Ventaira Pharmaceuticals, Inc.
 Ventaira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ventaira Pharmaceuticals Inc. develops aerosol devices. It offers inhaled drugs, including fentanyl for the treatment of breakthrough pain and salmeterol/flucticasone for asthma. The company was founded in April 2000 and is headquartered in Columbus, OH. | Health Technology |
Draupnir LLC
 Draupnir LLC Investment ManagersFinance Draupnir LLC (Draupnir) is a private equity firm founded in 2002 by Jeremy W. Hobbs. The firm is headquartered in Illinois, Chicago. | Finance |
Genomics Collaborative, Inc.
 Genomics Collaborative, Inc. Medical SpecialtiesHealth Technology Genomics Collaborative, Inc. provides clinical samples and applies human genetics to target validation for drug discovery. The company is based in Cambridge, MA. The company was founded by Phyllis I. Gardner and Edward E. Harlow. Genomics Collaborative was acquired by BioServe Biotechnologies Ltd., a SUB of ReproCELL, Inc. from SeraCare Life Sciences, Inc. on May 29, 2007 for $2 million. | Health Technology |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | Finance |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Avestria Ventures Management, LLC
Avestria Ventures Management, LLC Investment ManagersFinance Avestria Ventures Management LLC (Avestria Ventures) is a venture capital firm founded in 2018 by Linda M. Greub and Corinne H. Nevinny. The firm is headquartered in San Francisco, California. | Finance |
| Aronex Pty Ltd. |
